suicide gene therapy (SATT CONECTUS ALSACE)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namesuicide gene therapy (SATT CONECTUS ALSACE)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSATT Conectus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSATT Conectus
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A